FDA directs MannKind to conduct 2 new studies on inhaled insulin
Vittorio Hernandez – AHN News D.C., Washington, United States (AHN) – The U.S. Food and Drug Administration asked on Wednesday MannKind to conduct two new studies on inhaled insulin for Type 1 and Type 2 diabetics. With the FDA order, the company will have to delay the drug’s release in the market by 18 to [...]
Comments Off
